Clinical trial
Evaluation of Myocardial Dysfunction Due to mRNA-based SARS-CoV-2 Vaccines
NCT05359250 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Myocardial Dysfunction Due to mRNA-based SARS-CoV-2 Vaccines
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 12, 2021
- Completion date
- December 30, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, myocardial injury, vaccine reaction